NBY
NovaBay Pharmaceuticals, Inc.Recent alerts on NBY
All signals →
SEC filing
SDEV Reports $552.4M GAAP Net Income, $22.3M Operating Income, Q1 2026
13d ago
Insider trade
Purchase by R01 Fund LP
13d ago
Insider trade
Purchase by R01 Capital LLC
13d ago
Insider trade
Purchase by R01 Capital Manager LLC
13d ago
Insider trade
Purchase by Framework Ventures IV L.P.
13d ago
Insider trade
Purchase by Framework Ventures Management LLC
13d ago
Insider trade
Purchase by Framework Ventures IV GP LLC
13d ago
Insider trade
Purchase by Spencer Vance
13d ago
Insider trade
Purchase by Anderson Michael Ernest
13d ago
Insider trade
Purchase by Kazley Michael John (Chief Executive Officer)
13d ago
SEC filing
NBY Amends Charter to Remove Consent Ban, Exculpate Officers, Authorize 5B Shares; Stockholders Approve 6 Proposals Including 5.4M Share Issuance, 837.7M Share Issuance, 5B Authorized Shares, 2026 Equity Plan
81d ago
SEC filing
NBY Changes Auditor, No Disagreements, Seeks New Firm
124d ago
Scanner
Unusual volume (z=54.1)
160d ago
Scanner
Unusual volume (z=46.4)
161d ago
Scanner
Unusual volume (z=46.4)
163d ago
Scanner
Unusual volume (z=46.4)
164d ago
Get push alerts for NBY
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS